KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Rad Laboratories (BIO) Free Cash Flow (2016 - 2025)

Bio-Rad Laboratories (BIO) has disclosed Free Cash Flow for 17 consecutive years, with $119.1 million as the latest value for Q4 2025.

  • Quarterly Free Cash Flow rose 46.49% to $119.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $374.6 million through Dec 2025, up 29.35% year-over-year, with the annual reading at $374.6 million for FY2025, 29.35% up from the prior year.
  • Free Cash Flow for Q4 2025 was $119.1 million at Bio-Rad Laboratories, up from $89.2 million in the prior quarter.
  • The five-year high for Free Cash Flow was $195.7 million in Q3 2021, with the low at -$16.6 million in Q3 2022.
  • Average Free Cash Flow over 5 years is $75.0 million, with a median of $67.1 million recorded in 2023.
  • The sharpest move saw Free Cash Flow crashed 108.47% in 2022, then surged 423.45% in 2023.
  • Over 5 years, Free Cash Flow stood at $114.7 million in 2021, then plummeted by 60.95% to $44.8 million in 2022, then decreased by 13.53% to $38.7 million in 2023, then soared by 109.89% to $81.3 million in 2024, then surged by 46.49% to $119.1 million in 2025.
  • According to Business Quant data, Free Cash Flow over the past three periods came in at $119.1 million, $89.2 million, and $70.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.